未來世界控股(00572.HK):在OJABIO獨家授權下致力於分銷檢測盒
格隆匯 12 月 1日丨未來世界控股(00572.HK)發佈公告,面對當前新型冠狀病毒(COVID-19)疫情爆發及於全球蔓延,集團預計全球對相關檢測產品的需求將會持續。公司的全資附屬公司天信國際投資有限公司已按獨家基準獲授權及委任為温州甌佳生物科技有限公司(亦稱為OJABIO)有關以下各項的中國香港獨家授權分銷商(不包括中國內地):(1) COVID-19抗原檢測盒;及(2) COVID-19即時聚合酶連鎖反應檢測盒(統稱“檢測盒”),由2020年11月25日起為期三年。檢測盒為用於定性確定人體存在COVID-19的有效及高效檢測盒,並可為社會提供可負擔“早期診斷”解決方案。檢測盒亦已取得相關認證。
根據披露,OJABIO為一間於中華人民共和國成立的公司,主要以獨立研發專利從事遺傳病的輔助診斷。據公司董事所深知及盡悉,OJABIO及其最終實益擁有人為獨立第三方。集團將運用於貿易及分銷業務方面的過往經驗及專業知識,在OJABIO的獨家授權下,致力於全球範圍內(包括中國香港及世界其他地區,惟不包括中國內地)分銷檢測盒。公司將繼續尋求機會擴大業務範圍,為股東帶來最大回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.